首页> 美国卫生研究院文献>The Journal of Automatic Chemistry >Spectrophotometric Methods for Simultaneous Determination of Oxytetracycline HCl and Flunixin Meglumine in Their Veterinary Pharmaceutical Formulation
【2h】

Spectrophotometric Methods for Simultaneous Determination of Oxytetracycline HCl and Flunixin Meglumine in Their Veterinary Pharmaceutical Formulation

机译:分光光度法同时测定兽药中盐酸土霉素和氟尼辛葡胺含量。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Four precise, accurate, selective, and sensitive UV-spectrophotometric methods were developed and validated for the simultaneous determination of a binary mixture of Oxytetracycline HCl (OXY) and Flunixin Meglumine (FLU). The first method, dual wavelength (DW), depends on measuring the difference in absorbance (ΔA 273.4–327 nm) for the determination of OXY where FLU is zero while FLU is determined at ΔA 251.7–275.7 nm. The second method, first-derivative spectrophotometric method (1D), depends on measuring the peak amplitude of the first derivative selectively at 377 and 266.7 nm for the determination of OXY and FLU, respectively. The third method, ratio difference method, depends on the difference in amplitudes of the ratio spectra at ΔP 286.5–324.8 nm and ΔP 249.6–286.3 nm for the determination of OXY and FLU, respectively. The fourth method, first derivative of ratio spectra method (1DD), depends on measuring the amplitude peak to peak of the first derivative of ratio spectra at 296.7 to 369 nm and 259.1 to 304.7 nm for the determination of OXY and FLU, respectively. Different factors affecting the applied spectrophotometric methods were studied. The proposed methods were validated according to ICH guidelines. Satisfactory results were obtained for determination of both drugs in laboratory prepared mixture and pharmaceutical dosage form. The developed methods are compared favourably with the official ones.
机译:开发并验证了四种精确,准确,选择性和灵敏的紫外分光光度法,用于同时测定盐酸土霉素(OXY)和氟尼辛葡甲胺(FLU)的二元混合物。第一种方法是双波长(DW),取决于测量吸光度差(ΔA273.4–327 nm)以确定OXY,其中FLU为零,而FLU在ΔA251.7–275.7 nm处确定。第二种方法,即一阶导数分光光度法(1D),取决于分别测量一阶导数在377和266.7nm处的峰幅度,以确定OXY和FLU。第三种方法是比率差法,分别取决于测定OXY和FLU的比率谱在ΔP286.5–324.8 andnm和ΔP249.6–286.3 nm处的振幅差。第四种方法是比率光谱法的一阶导数(1DD),取决于分别在296.7至369 nm和259.1至304.7 nm处测量比率谱的一阶导数的幅度峰到峰,以确定OXY和FLU。研究了影响应用分光光度法的不同因素。根据ICH指南对提出的方法进行了验证。测定实验室制备的混合物和药物剂型中的两种药物均获得了令人满意的结果。所开发的方法可与官方方法相媲美。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号